ZebiAI

ZebiAI Therapeutics Focuses on Applying Machine Learning (ML) in All Stages of Small Molecule Drug Discovery to Accelerate Target Validation and Provide New Therapies for Unmet Medical Needs. Our Core Technology Applies ML Algorithms to Large Quantities of High-Quality Protein-Small Molecule Interaction Data, Accelerating Target Validation and Rapidly Discovering New Chemicals and Optimizing Them into Clinical Candidates by Providing the Research Community with High-Quality Chemical Probe Molecules.By Generating Novel Small Molecule Probes to Drive a Deeper Understanding of Biology, Our Chemome Initiative Provides Academic Researchers with Chemical Probe Molecules to Explore the Functions of Their Selected Proteins. ZebiAI Is Committed to Actively Supporting the Publication of Research Findings in Peer-Reviewed Journals. We Are Passionate About Deepening Biological Knowledge and Accelerating Target Validation by Providing Probe Compounds for Thousands of Targets Identified in Academia.